Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ORTI-A.STthis companyOrtivus AB (publ)	SEK 1.76	-2.9×	2.8×	0.86×	-6.94×	-251.1%	40.3%	-19.7%	-29.8%	-97.6%	-34.4%	-55.5%	0.87×	-1.01×	-7.78×	0.98×	0.0%	1	0.65	1	D+
ACOU.STAcouSort AB	SEK 3.12	-4.42×	3.27×	7.79×	-3.29×	-1703.2%	-211.6%	-211.6%	-177.3%	-74.6%	-89.0%	-32.4%	0×	0.44×	-10.85×	8.19×	0.0%	2	-4.93	1	D+
AINO.STAino Health AB (publ)	SEK 0.18	-5.72×	-5.45×	1.34×	-11.4×	9.1%	-16.4%	-20.0%	-23.4%	95.1%	-278.5%	-6.9%	-1.3×	-0.77×	-6.08×	0.89×	0.0%	3	-0.85	2	C
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	SEK 0.91	-1.19×	1.27×	12.37×	0×	1336.2%	-1171.5%	-1444.4%	-1041.4%	-106.7%	-121.9%	-90.4%	0.06×	0.88×	-117.12×	2.04×	0.0%	2	-2.66	3	B
HEART.STScandinavian Real Heart AB (Publ)	SEK 16.40	-1.96×	1.11×	0×	-3.8×	-85.9%	0.0%	0.0%	0.0%	-56.8%	-22.9%	-23.8%	0.07×	0.8×	-41.14×	2.5×	0.0%	3	8.38	2	C
MODTX.STModus Therapeutics Holding AB	SEK 0.17	-1.01×	2.1×	0×	-0.42×	4.5%	0.0%	0.0%	0.0%	-204.4%	-200.3%	-94.9%	0×	0.63×	-45.3×	3.51×	0.0%	1	-38.3	2	C
Peer median	—	-1.96×	1.27×	1.34×	-3.29×	4.5%	-16.4%	-20.0%	-23.4%	-74.6%	-121.9%	-32.4%	0×	0.63×	-41.14×	2.5×	0.0%	2	-2.66	2	—